SYSTEMIC SCLEROSIS-ASSOCIATED PRECAPILLARY PULMONARY HYPERTENSION WITH AND WITHOUT INTERSTITIAL LUNG DISEASE: OBSERVATIONS FROM A SINGLE REFERRAL CENTER COHORT

被引：1
|
作者：
Ahmad, Yousef
Zhou, Christine
Olmstead, Keegan
Khan, Sarah
Windholz, Julie
Gupta, Nishant
Gomez-Arroyo, Jose
Elwing, Jean
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.991
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1076A / 1077A
页数：2
相关论文
共 50 条
  • [1] Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival A Large Cohort Study of the German Network for Systemic Sclerosis
    Moinzadeh, Pia
    Bonella, Francesco
    Oberste, Max
    Weliwitage, Jithmi
    Blank, Nobert
    Riemekasten, Gabriela
    Mueller-Ladner, Ulf
    Henes, Joerg
    Siegert, Elise
    Guenther, Claudia
    Koetter, Ina
    Pfeiffer, Christiane
    Schmalzing, Marc
    Zeidler, Gabriele
    Korsten, Peter
    Susok, Laura
    Juche, Aaron
    Worm, Margitta
    Jandova, Ilona
    Ehrchen, Jan
    Sunderkoetter, Cord
    Keysser, Gernot
    Ramming, Andreas
    Schmeiser, Tim
    Kreuter, Alexander
    Lorenz, Hanns-Martin
    Hunzelmann, Nicolas
    Kreuter, Michael
    CHEST, 2024, 165 (01) : 132 - 145
  • [2] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [3] Systemic sclerosis-associated interstitial lung disease
    Perelas, Apostolos
    Silver, Richard M.
    Arrossi, Andrea, V
    Highland, Kristin B.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (03): : 304 - 320
  • [4] A Large Proportion of Patients in an Early Systemic Sclerosis-Associated Interstitial Lung Disease Cohort Have Coexisting Pulmonary Hypertension
    Young, Amber
    Fisher, Caitlyn
    Namas, Rajaie
    Wilhalme, Holly
    Khanna, Dinesh
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [6] CHARACTERISTICS OF QUANTITATIVE CT ANALYSIS AND PULMONARY HYPERTENSION IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Jesudasen, Sirus
    Patel, Badar
    D'Silva, Kristin
    Nardelli, Pietro
    Estepar, Ruben San Jose
    Washko, George
    Estepar, Raul San Jose
    Rahaghi, Farbod
    Montesi, Sydney
    CHEST, 2021, 160 (04) : 2145A - 2146A
  • [7] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [8] Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension
    Andrade, F. M.
    Oliveira, A. D.
    Lopes, A. J.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2019, 52 (08)
  • [9] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
    Moran-Mendoza, Onofre
    Alharthi, Bader
    Clements-Baker, Marie
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1595 - 1595
  • [10] Management of systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Jaafar, Sara
    Vummidi, Dharshan
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 241 - 249
12345